UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital, Houston

RekruttererFase 2

59 Months · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05535166

OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy

MD Anderson Cancer Center, Houston

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07655583

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

M D Anderson Cancer Center, Houston

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT04988009

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NEXT Oncology - Austin, Austin
Mary Crowley Cancer Research, Dallas
MD Anderson Cancer Center - University of Texas, Houston

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

MD Anderson Cancer Center, Houston

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07467109

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

University of Texas MD Anderson Cancer Center, Houston

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT05386108

Targeted Pediatric High-Grade Glioma Therapy

Texas Children's Hospital, Houston

RekruttererObservasjonsstudie

12 Months – 39 Years · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

UT MD Anderson Cancer Center, Houston
UT Health San Antonio Mays Cancer Center, San Antonio

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07428616

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

MD Anderson Cancer Center, Houston

RekruttererFase 1

36 Months – 22 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

Texas Children's Hospital, Houston

RekruttererFase 2

Alder 12 til 39 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06161974

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

MD Anderson Cancer Center, Houston
Community Clinical Trials, Kingwood
Tranquil Clinical Research, Webster

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06764940

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

Ut Southwestern Medical Center, Dallas

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07139990

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

Mary Crowley Cancer Research, Dallas
The University of Texas M.D. Anderson Cancer Center, Houston

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06136884

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Houston Methodist Neal Cancer Center, Houston

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07383649

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Excel Diagnostics & Nuclear Oncology Center, Houston

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Texas Children's Hospital, Houston

RekruttererFase 1

12 Months – 25 Years · Alle kjønn · Oppdatert 3. aug. 2026 · NCT04099797

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

UT Southwestern Simmons Cancer Center, Dallas
Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
Houston Methodist Hospital, Houston
og 2 flere

RekruttererObservasjonsstudie

Alle aldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04427384

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

M D Anderson Cancer Center, Houston

RekruttererFase 1

Alder 19 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT03830151

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

M D Anderson Cancer Center, Houston

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT05673928

Mapping of Human Cognition

The University of Texas Health Science Center at Houston, Houston

Rekrutterer

Alder 18 til 75 · Alle kjønn · Oppdatert 14. jul. 2026 · NCT05989893

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Texas Children's Hospital, Houston

RekruttererFase 2

12 Months – 39 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT05843253

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

M D Anderson Cancer Center, Houston

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT02754544

A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain

M D Anderson Cancer Center, Houston

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT05342454

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

M D Anderson Cancer Center, Houston

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT05064280

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active

The University of Texas MD Anderson Cancer Center, Houston

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2026 · NCT06649058

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

MD Anderson Cancer Center, Houston

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06810544

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Md Anderson Cancer Center, Houston

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04075305

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

M D Anderson Cancer Center, Houston

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT05700721

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Elligo Health Research, Inc., Austin

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

MD Anderson Cancer Center, Houston

Rekrutterer

Alder 15 til 39 · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06799481

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
UT Southwestern Clinical Center at Richardson/Plano, Richardson

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 8. okt. 2025 · NCT03418961

Systematic Light Exposure in Pediatric Brain Tumor Survivors

Texas Children's Hospital, Houston

Rekrutterer

Alder 10 til 18 · Alle kjønn · Oppdatert 18. sep. 2025 · NCT05340881

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

MD Anderson, Houston
NEXT Oncology, San Antonio

RekruttererFase 1/2

Alder 18 til 89 · Alle kjønn · Oppdatert 19. aug. 2025 · NCT06907043

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.